시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 종양학 분석 솔루션용 AI 시장 보고서(2025년)
AI In Oncology For Analytical Solutions Global Market Report 2025
상품코드 : 1824567
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,457,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,334,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,211,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

종양학 분석 솔루션용 AI 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년에는 CAGR 34.2%를 나타내 46억 7,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 맞춤형 의료에 대한 수요 증가, 건강 관리 의식 증가, 멀티오믹스 데이터 통합, 규제 정교화, 원격 의료 및 원격 진단으로 인한 것으로 예측됩니다. 예측 기간의 주요 동향으로는 공동연구와 파트너십, 지속적인 기술진보, 산업연계, R&D 이니셔티브, 기술진보 등이 있습니다.

향후 5년간의 성장률이 34.2%인 예측은 전회의 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 상승은 프랑스와 싱가포르에서 조달한 인공지능(AI) 기반의 종양 등록 분석과 치료 최적화 알고리즘의 비용을 끌어올려, 가치 기반 의료의 도입 비용을 악화시켜, 맞춤형 치료의 결정을 늦추는 것으로, 미국의 암 센터에 부담을 줄 가능성이 높습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

암 유병률 증가는 종양학 분석 솔루션용 AI 시장 확대를 촉진할 것으로 예측됩니다. 암은 비정상 세포의 통제 불가능한 증식과 확산을 특징으로 하는 질환군입니다. 종양학 분석 솔루션용 AI은 대량의 복잡한 데이터를 신속하고 효율적으로 처리할 수 있는 능력을 통해 맞춤형 치료, 조기 발견, 환자의 결과 개선을 가능하게 함으로써 암 치료에 중요한 역할을 하고 있습니다. 예를 들어 2024년 5월 미국 정부기관인 국립암연구소에 따르면 2024년 미국에서 새로 약 200만명의 암 환자가 진단되어 61만 1,000명 이상의 암 관련 사망이 발생했습니다. 2040년까지는 세계 신규 암 환자는 2,990만명으로 증가하며, 암 관련 사망은 1,530만명에 달할 것으로 예측됩니다. 그 결과, 암 유병률 증가가 종양학 분석 솔루션용 AI의 성장을 견인하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

AI in oncology for analytical solutions involves the utilization of artificial intelligence (AI) technology within the oncology field to develop advanced analytical solutions for cancer research, diagnosis, and treatment. This technology aids healthcare professionals in making data-driven decisions, enhancing diagnostic accuracy, and customizing treatment plans.

The primary components in AI in oncology for analytical solutions include data licensing services, software solutions, analytics, and other related elements. Data licensing entails the process of granting or obtaining legal permission to utilize and access data, typically through a contractual agreement between the data provider (licensor) and the data user (licensee). These solutions encompass various treatment types such as chemotherapy, radiotherapy, immunotherapy, and others, catering to a wide array of cancer types including breast cancer, lung cancer, prostate cancer, colorectal cancer, brain tumors, kidney cancer, non-Hodgkin lymphoma, and bladder cancer.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The AI in oncology for analytical solutions market research report is one of a series of new reports from The Business Research Company that provides AI in oncology for analytical solutions market statistics, including AI in oncology for analytical solutions industry global market size, regional shares, competitors with a AI in oncology for analytical solutions market share, detailed AI in oncology for analytical solutions market segments, market trends and opportunities, and any further data you may need to thrive in the AI in oncology for analytical solutions industry. This AI in oncology for analytical solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ai in oncology for analytical solutions market size has grown exponentially in recent years. It will grow from $1.07 billion in 2024 to $1.44 billion in 2025 at a compound annual growth rate (CAGR) of 34.4%. The growth in the historic period can be attributed to increasing healthcare data availability, rising awareness and acceptance, advancements in machine learning algorithms, government initiatives and funding, clinical acceptance.

The ai in oncology for analytical solutions market size is expected to see exponential growth in the next few years. It will grow to $4.67 billion in 2029 at a compound annual growth rate (CAGR) of 34.2%. The growth in the forecast period can be attributed to rising demand for personalized medicine, increasing healthcare awareness, integration of multi-omics data, regulatory refinement, telemedicine and remote diagnostics. Major trends in the forecast period include collaborations and partnerships, continuous technological advancements, industry collaborations, research and development initiatives, advancements in technology.

The forecast of 34.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. cancer centers by driving up the cost of Artificial intelligence(AI)-based tumor registry analytics and treatment optimization algorithms sourced from France and Singapore, exacerbating value-based care implementation costs and delaying personalized therapy decisions. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of cancer is expected to drive the expansion of the AI in oncology for analytical solutions market. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells. AI in oncology for analytical solutions plays a significant role in cancer care by enabling personalized treatment, early detection, and improved patient outcomes through its capacity to process large volumes of complex data quickly and efficiently. For example, in May 2024, the National Cancer Institute, a US-based government agency, projected that in 2024, approximately 2 million new cancer cases would be diagnosed in the U.S., with over 611,000 cancer-related deaths. By 2040, new cancer cases globally are expected to rise to 29.9 million, with cancer-related deaths reaching 15.3 million. As a result, the increasing prevalence of cancer is driving the growth of AI in oncology for analytical solutions.

Prominent companies in the AI in oncology for analytical solutions market are focusing on advancing AI technologies, including the development of new real-world data platforms to accelerate cancer research and enhance generative AI models in oncology. A real-world data platform integrates and manages observational data from diverse sources outside of conventional clinical research settings, such as electronic health records, health insurance claims, patient surveys, and disease registries. For instance, in October 2023, the Central Ohio Transit Authority in the US launched Vista, a new real-world data platform designed to expedite cancer research and enhance generative AI models in oncology. Vista integrates multiple databases, including the data portal database and the genomic database, to provide a comprehensive and standardized approach to managing cancer research data. Additionally, Vista is expected to facilitate data sharing, enhance data quality, and support various applications in oncology and other healthcare domains.

In December 2023, ConcertAI, an India-based medical research developer, acquired CancerLinQ, a US-based cancer treatment company specializing in AI-based data and analytics, aiming to establish the leading healthcare learning and research network in oncology. This acquisition seeks to provide members with upgraded quality reporting, industry-leading real-world data, and AI-powered solutions to accelerate clinical trials.

Major companies operating in the AI in oncology for analytical solutions market report are IBM Watson Health, NVIDIA Corporation, Siemens Healthineers, GE Healthcare, Tempus, DeepMind Health, Paige.AI, PathAI, Aidoc, Nucleai, HeartFlow, OWKIN, SOPHiA Genetics, Imagen Technologies, Butterfly Network, Atomwise, Enlitic, Inspirata, 3Scan, Zebra Medical Vision, Ibex Medical Analytics, Vuno Inc., Proscia, Google Health, Huiying Medical

North America was the largest region in the AI In oncology for analytical solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the AI in oncology for analytical solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the AI in oncology for analytical solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The AI in oncology for analytical solutions market consists of revenues earned by entities by providing services such as consulting services, implementation services, training services, medical imaging analysis services, genomic data interpretation services, and drug discovery and development solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in oncology for analytical solutions market also includes sales of AI-powered imaging tools, drug discovery and development devices, and recurrence monitoring systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

AI In Oncology For Analytical Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ai in oncology for analytical solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for ai in oncology for analytical solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ai in oncology for analytical solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. AI In Oncology For Analytical Solutions Market Characteristics

3. AI In Oncology For Analytical Solutions Market Trends And Strategies

4. AI In Oncology For Analytical Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global AI In Oncology For Analytical Solutions Growth Analysis And Strategic Analysis Framework

6. AI In Oncology For Analytical Solutions Market Segmentation

7. AI In Oncology For Analytical Solutions Market Regional And Country Analysis

8. Asia-Pacific AI In Oncology For Analytical Solutions Market

9. China AI In Oncology For Analytical Solutions Market

10. India AI In Oncology For Analytical Solutions Market

11. Japan AI In Oncology For Analytical Solutions Market

12. Australia AI In Oncology For Analytical Solutions Market

13. Indonesia AI In Oncology For Analytical Solutions Market

14. South Korea AI In Oncology For Analytical Solutions Market

15. Western Europe AI In Oncology For Analytical Solutions Market

16. UK AI In Oncology For Analytical Solutions Market

17. Germany AI In Oncology For Analytical Solutions Market

18. France AI In Oncology For Analytical Solutions Market

19. Italy AI In Oncology For Analytical Solutions Market

20. Spain AI In Oncology For Analytical Solutions Market

21. Eastern Europe AI In Oncology For Analytical Solutions Market

22. Russia AI In Oncology For Analytical Solutions Market

23. North America AI In Oncology For Analytical Solutions Market

24. USA AI In Oncology For Analytical Solutions Market

25. Canada AI In Oncology For Analytical Solutions Market

26. South America AI In Oncology For Analytical Solutions Market

27. Brazil AI In Oncology For Analytical Solutions Market

28. Middle East AI In Oncology For Analytical Solutions Market

29. Africa AI In Oncology For Analytical Solutions Market

30. AI In Oncology For Analytical Solutions Market Competitive Landscape And Company Profiles

31. AI In Oncology For Analytical Solutions Market Other Major And Innovative Companies

32. Global AI In Oncology For Analytical Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The AI In Oncology For Analytical Solutions Market

34. Recent Developments In The AI In Oncology For Analytical Solutions Market

35. AI In Oncology For Analytical Solutions Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기